Class information for:
Level 1: BREAKTHROUGH PAIN//OPIOID ROTATION//CANCER PAIN

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
5260 1581 33.3 70%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1638 6431 TRAMADOL//BREAKTHROUGH PAIN//MORPHINE 6 GLUCURONIDE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 BREAKTHROUGH PAIN Author keyword 245 83% 9% 136
2 OPIOID ROTATION Author keyword 71 76% 3% 50
3 CANCER PAIN Author keyword 63 21% 17% 261
4 FENTANYL BUCCAL TABLET Author keyword 61 95% 1% 20
5 BREAKTHROUGH CANCER PAIN Author keyword 55 92% 1% 22
6 OXYCODONE Author keyword 54 31% 9% 142
7 TRANSDERMAL FENTANYL Author keyword 45 62% 3% 47
8 ORAL TRANSMUCOSAL FENTANYL CITRATE Author keyword 42 94% 1% 15
9 PAIN RELIEF PALLIAT CARE UNIT Address 32 38% 4% 68
10 OPIOID SWITCHING Author keyword 25 75% 1% 18

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 BREAKTHROUGH PAIN 245 83% 9% 136 Search BREAKTHROUGH+PAIN Search BREAKTHROUGH+PAIN
2 OPIOID ROTATION 71 76% 3% 50 Search OPIOID+ROTATION Search OPIOID+ROTATION
3 CANCER PAIN 63 21% 17% 261 Search CANCER+PAIN Search CANCER+PAIN
4 FENTANYL BUCCAL TABLET 61 95% 1% 20 Search FENTANYL+BUCCAL+TABLET Search FENTANYL+BUCCAL+TABLET
5 BREAKTHROUGH CANCER PAIN 55 92% 1% 22 Search BREAKTHROUGH+CANCER+PAIN Search BREAKTHROUGH+CANCER+PAIN
6 OXYCODONE 54 31% 9% 142 Search OXYCODONE Search OXYCODONE
7 TRANSDERMAL FENTANYL 45 62% 3% 47 Search TRANSDERMAL+FENTANYL Search TRANSDERMAL+FENTANYL
8 ORAL TRANSMUCOSAL FENTANYL CITRATE 42 94% 1% 15 Search ORAL+TRANSMUCOSAL+FENTANYL+CITRATE Search ORAL+TRANSMUCOSAL+FENTANYL+CITRATE
9 OPIOID SWITCHING 25 75% 1% 18 Search OPIOID+SWITCHING Search OPIOID+SWITCHING
10 OPIOID SWITCH 23 86% 1% 12 Search OPIOID+SWITCH Search OPIOID+SWITCH

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 TRANSDERMAL FENTANYL 70 39% 9% 141
2 BREAKTHROUGH CANCER PAIN 67 85% 2% 35
3 BREAKTHROUGH PAIN 61 43% 7% 107
4 TRANSMUCOSAL FENTANYL CITRATE 59 52% 5% 82
5 ORAL METHADONE 58 61% 4% 62
6 RELEASE ORAL MORPHINE 55 65% 3% 53
7 BUCCAL TABLET 42 83% 2% 24
8 CANCER PAIN 41 13% 18% 292
9 OPIOID ROTATION 35 49% 3% 53
10 INCIDENT PAIN 35 89% 1% 16

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC 2012 143 68 60%
Prevalence of Breakthrough Cancer Pain: A Systematic Review and a Pooled Analysis of Published Literature 2014 10 49 59%
The management of cancer-related breakthrough pain: Recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland 2009 114 36 81%
A Network Meta-Analysis of the Efficacy of Opioid Analgesics for the Management of Breakthrough Cancer Pain Episodes 2014 8 42 64%
Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review 2011 28 45 100%
Efficacy of Rapid-Onset Oral Fentanyl Formulations vs. Oral Morphine for Cancer-Related Breakthrough Pain: A Meta-Analysis of Comparative Trials 2013 11 21 86%
Pharmacotherapy for Breakthrough Cancer Pain 2012 20 34 100%
Opioid switching: A systematic and critical review 2006 80 41 90%
Contribution of oxycodone and its metabolites to the overall analgesic effect after oxycodone administration 2013 9 52 83%
Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey 2004 122 23 70%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PAIN RELIEF PALLIAT CARE UNIT 32 38% 4.3% 68
2 ANESTHESIA INTENS CARE UNIT 7 17% 2.3% 37
3 TOR VERGATA POLYCLIN 4 47% 0.4% 7
4 GREY NUNS COMMUNITY HLTH 4 67% 0.3% 4
5 ANESTHESIA INTENS CARE EMERGENCIES 4 75% 0.2% 3
6 EMERGENCY CARE CRIT CARE MED PAIN MED ANESTHESI 4 75% 0.2% 3
7 PAIN RELIEF SUPPORT CARE UNIT 4 75% 0.2% 3
8 PAIN MED PALLIAT CARE 4 14% 1.5% 23
9 PAIN PALLIAT GRP 3 22% 0.9% 14
10 EMERGENCY CARE CRIT CARE MED PAIN MED ANAESTHES 3 57% 0.3% 4

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000191834 CANCER PAIN//CANCER PAIN MANAGEMENT//PAIN MANAGEMENT
2 0.0000183650 MORPHINE 6 GLUCURONIDE//MORPHINE 3 GLUCURONIDE//MORPHINE GLUCURONIDES
3 0.0000142471 CHRONIC NONCANCER PAIN//OPIOIDS//PRESCRIPTION MONITORING PROGRAMS
4 0.0000120565 METHADONE//EDDP//2 ETHYLIDENE 1 5 DIMETHYL 3 3 DIPHENYLPYRROLIDINE
5 0.0000113116 NORFENTANYL//MUSCULAR RIGIDITY//SUFENTANIL
6 0.0000106857 PATIENT CONTROLLED ANALGESIA//ACUTE PAIN SERVICE//ANALGESIA PATIENT CONTROLLED
7 0.0000090092 ZICONOTIDE//INTRATHECAL PUMP//INTRATHECAL DRUG DELIVERY SYSTEM
8 0.0000079346 OPRM1//A118G//OPRM1 GENE
9 0.0000073464 NEUROSYST//MOL NEUROBIOL PAIN//BMS182874 5 DIMETHYLAMINO N 3 4 DIMETHYL 5 ISOXAZOLYD 1 NAPHTHALENESULFONAMIDE
10 0.0000069431 MALIGNANT BOWEL OBSTRUCTION//BOWEL OBSTRUCTION//VENTING GASTROSTOMY